Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

Delayed Quote. Delayed  - 04/29 10:02:15 pm
38.9 USD   -3.76%
04:58a ST JUDE MEDICAL : Abbott is counting on growth turnaround at St. Jud..
04/29 ABBOTT LABORATO : buys St. Jude Medical for $19.3 billion
04/29 CORRECTION : Abbott-St Jude Acquisition story
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales21 84820 24720 40520 91222 15423 435
Operating income (EBITDA)4 9745 8624 8505 1325 5486 012
Operating profit (EBIT)4 0464 3143 9793 9784 3824 845
Pre-Tax Profit (EBT)2 521-----
Net income2 5762 2844 4232 3443 2503 532
P/E ratio23,730,215,421,416,815,1
EPS ( $ )1,621,492,921,822,322,57
Dividend per Share ( $ )0,640,900,981,031,131,23
Yield1,67%2,00%2,18%2,64%2,90%3,17%
Reference price ( $ )38.3345.0244.9138.938.938.9
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt3 0863 7822 8763 4093 2842 696
Finance------
Operating income (EBITDA)4 9745 8624 8505 1325 5486 012
Leverage
(Debt/EBITDA)
0,62x0,65x0,59x0,66x0,59x0,45x
Capital Expenditure1 1451 0771 1101 1441 1811 262
Book Value Per Share (BVPS)16,3 $14,3 $14,4 $14,3 $16,3 $16,3 $
Cash Flow per Share2,11 $2,41 $1,97 $2,75 $3,35 $3,72 $
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 57 309 M$ -
Entreprise Value (EV) 60 719 M$ 60 593 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 21,4x 16,8x
Capitalization / Revenue 2,74x 2,59x
EV / Revenue 2,90x 2,74x
EV / EBITDA 11,8x 10,9x
Yield (DPS / Price) 2,64% 2,90%
Price to book (Price / BVPS) 2,71x 2,39x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,0% 19,8%
operating Leverage (Delta EBIT / Delta Sales) - 1,71x
Net Margin (Net Profit / Revenue) 11,2% 14,7%
ROA (Net Profit / Asset) 7,97% 8,86%
ROE (Net Profit / Equities) 15,2% 15,8%
Rate of Dividend 56,5% 48,6%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   5,47% 5,33%
Cash Flow / Sales 19,4% 22,3%
Capital Intensity (Assets / Sales) 1,41x 1,66x
Financial Leverage (Net Debt / EBITDA) 0,66x 0,59x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend